Skip to content

Does Kaiser Permanente cover Wegovy and Zepbound?

By the glp1doses editorial team
Every number is checked against FDA labels and official price pages. How we check

The short answer

Kaiser Permanente Northwest covers Wegovy injection and Zepbound for weight loss only if your plan includes coverage for weight-loss medications. If you have the benefit, you must first fail a 3-month trial of at least two older weight-loss medicines, and Zepbound also requires at least 6 months of semaglutide. Other Kaiser regions set their own rules.

Key takeaways

  • In the Northwest region, Wegovy and Zepbound are covered for weight loss only on plans with that benefit.
  • You must fail a 3-month trial of at least two older weight-loss medicines first, unless you can't take them.
  • Zepbound also requires a failed trial of at least 6 months of semaglutide, or being unable to take it.
  • Expect a weigh-in close to the request. Weight and BMI must be documented in about the last 30 days.
  • Outside the Northwest, ask your region's member services or pharmacy for its own criteria.

What the published policies say

  • Kaiser Permanente Northwest: Wegovy commercial excluded benefit unless rider

    In Kaiser Permanente's Northwest region, Wegovy injection is covered for weight loss only for members whose plan includes coverage for weight-loss medications; everyone else pays the member cash price. Members with that benefit must also meet clinical criteria, including trying at least two older weight-loss medicines first. Other Kaiser regions set their own rules.

    • Plan must include a prescription benefit that covers weight-loss medications
    • Age 18 or older for chronic weight management, with weight and BMI documented in about the last 30 days
    • BMI of 30 or more, or 27 or more with a listed weight-related condition
    • Actively making lifestyle changes, or an active behavioral health referral
    • Failed a 3-month trial of at least two of: phentermine, diethylpropion, topiramate, phentermine/topiramate, naltrexone/bupropion (or cannot take them)
    • Continued coverage every 12 months requires keeping off at least 5 percent of body weight
    Wegovy injectable is covered under the prescription drug benefit for weight loss ONLY for Kaiser Northwest members with coverage for medications used to treat weight loss. Others pay member cash price.

    Kaiser Permanente Northwest Region Criteria for Drug Coverage: semaglutide injectable (Wegovy, Wegovy HD)

  • Kaiser Permanente Northwest: Zepbound commercial non preferred

    In Kaiser Permanente's Northwest region, Zepbound is non-formulary and needs a clinical review. It is covered for weight loss only for members whose plan includes coverage for weight-loss medications, and only after the patient has failed older weight-loss medicines and then a trial of semaglutide of at least six months. Other Kaiser regions set their own rules.

    • Plan must include a prescription benefit that covers weight-loss medications
    • Age 18 or older, with BMI of 30 or more, or 27 or more with a listed weight-related condition
    • Failed a 3-month trial of at least two older weight-loss medicines (or cannot take them)
    • Then failed at least 6 months of semaglutide (Ozempic/Wegovy), or cannot take it
    • Continued coverage every 12 months requires keeping off at least 5 percent of body weight
    Zepbound is covered under the prescription drug benefit for weight loss ONLY for Kaiser Northwest members with coverage for medications used to treat weight loss. Others pay member cash price. ... Patient has then failed a minimum 6-month trial of semaglutide (Ozempic/Wegovy)

    Kaiser Permanente Northwest Region Criteria for Coverage: tirzepatide (Zepbound)

Policies differ between plans from the same insurer and change during the year. Your own plan documents decide.

Kaiser Permanente is organized by region, and each region writes its own drug coverage criteria. The two documents in our records come from one of them: the Kaiser Permanente Northwest Region criteria for semaglutide injectable (Wegovy and Wegovy HD) and for tirzepatide (Zepbound). Don’t read anything here as the rule for Kaiser members in other regions.

The benefit comes first

Both documents open with the same gate. For Wegovy: “Wegovy injectable is covered under the prescription drug benefit for weight loss ONLY for Kaiser Northwest members with coverage for medications used to treat weight loss. Others pay member cash price.”

So start by finding out whether your plan includes a prescription benefit for weight-loss medications. If it doesn’t, the clinical criteria below don’t come into play, and you can get the drug only at the member cash price.

Wegovy injection: the clinical criteria

If you have the benefit, Kaiser Northwest asks for all of the following for chronic weight management:

  • Age 18 or older, with weight and BMI documented in about the last 30 days.
  • A BMI of 30 or more, or 27 or more with a listed weight-related condition.
  • Active lifestyle changes, or an active behavioral health referral.
  • A failed 3-month trial of at least two of these older medicines, unless you can’t take them: phentermine, diethylpropion, topiramate, phentermine/topiramate, naltrexone/bupropion.

The rule on a recent weight is unusual among the insurers we track. A BMI from last year’s physical won’t do, so expect a weigh-in close to the request.

Zepbound: one more step

Zepbound is non-formulary in the Northwest region and goes through a clinical review. The benefit gate, the age and the BMI rules match Wegovy’s. Then the steps stack. The member must have failed the 3-month trial of at least two older weight-loss medicines, and “then failed a minimum 6-month trial of semaglutide (Ozempic/Wegovy),” or be unable to take it.

In practice, that makes Zepbound the third step in this region, after the older medicines and after semaglutide.

Keeping coverage

Coverage is reviewed every 12 months for both medicines. To continue, the criteria require keeping off at least 5 percent of body weight.

What a Kaiser member can do

Kaiser is both your insurer and your care system, so the process usually runs inside it. Ask your Kaiser prescriber or pharmacy:

  1. Does my plan include coverage for medications used to treat weight loss?
  2. If yes, which of the step medicines have I already tried, and is that documented in my chart with dates?
  3. If I can’t take one of the step medicines, is the reason recorded?

If a request is declined, ask for the written reason and the criteria used. The denial appeal guide explains the general process, and the appeal letter generator helps you write to the plan. The prior authorization checklist shows how step therapy records (the proof of medicines tried first) are usually presented.

If your plan has no weight-loss medication benefit, compare the member cash price your Kaiser pharmacy quotes with the manufacturers’ self-pay programs, which start at $149 a month for Wegovy and $299 for Zepbound. The without-insurance guide has the detail, and the insurance guide covers other insurers.

Frequently asked questions

Does Kaiser cover Wegovy for weight loss?

In the Northwest region, only if your plan includes coverage for medications used to treat weight loss. Kaiser's criteria say others pay the member cash price. If you have the benefit, you must also meet clinical criteria, including a BMI of 30 or more, or 27 or more with a listed condition, and a failed 3-month trial of at least two older weight-loss medicines.

Does Kaiser cover Zepbound?

In Kaiser Permanente's Northwest region, Zepbound is non-formulary (not on the plan's list of covered drugs) and needs a clinical review. It's covered for weight loss only for members with a weight-loss medication benefit. You must fail a 3-month trial of at least two older weight-loss medicines and then at least 6 months of semaglutide, unless you can't take them.

Which medicines does Kaiser Northwest want tried before Wegovy?

The criteria list phentermine, diethylpropion, topiramate, phentermine/topiramate and naltrexone/bupropion. You must have failed a 3-month trial of at least two of them, or be unable to take them. Whether any of these is right for you is a decision for your Kaiser prescriber.

Do these rules apply to Kaiser in California or other regions?

The documents we hold are Kaiser Permanente Northwest Region criteria, and other Kaiser regions set their own rules. If you're a member elsewhere, ask your region's member services or pharmacy for its criteria for Wegovy and Zepbound, and whether your plan has a weight-loss medication benefit.

Sources (4)

  1. 1.
    Kaiser Permanente Northwest: Kaiser Permanente Northwest Region Criteria for Drug Coverage: semaglutide injectable (Wegovy, Wegovy HD)
    “Wegovy injectable is covered under the prescription drug benefit for weight loss ONLY for Kaiser Northwest members with coverage for medications used to treat weight loss. Others pay member cash price.”
  2. 2.
    Kaiser Permanente Northwest: Kaiser Permanente Northwest Region Criteria for Coverage: tirzepatide (Zepbound)
    “Zepbound is covered under the prescription drug benefit for weight loss ONLY for Kaiser Northwest members with coverage for medications used to treat weight loss. Others pay member cash price. ... Patient has then failed a minimum 6-month trial of semaglutide (Ozempic/Wegovy)”
  3. 3.
  4. 4.